To restrict our study to a period when a commercial serological system for HCMV IgG, IgM, and AI determination was available, we referred to the period October 2015–November 2018, when 1523 samples from 551 women with primary HCMV infection were prospectively collected and tested. This evidence concerns the gene CD40LG and cytomegalovirus infection.